199 related articles for article (PubMed ID: 29208932)
1. Mouse papillomavirus infection persists in mucosal tissues of an immunocompetent mouse strain and progresses to cancer.
Cladel NM; Budgeon LR; Balogh KK; Cooper TK; Brendle SA; Christensen ND; Schell TD; Hu J
Sci Rep; 2017 Dec; 7(1):16932. PubMed ID: 29208932
[TBL] [Abstract][Full Text] [Related]
2. The Mouse Papillomavirus Infection Model.
Hu J; Cladel NM; Budgeon LR; Balogh KK; Christensen ND
Viruses; 2017 Aug; 9(9):. PubMed ID: 28867783
[TBL] [Abstract][Full Text] [Related]
3. Passive Immunization with a Single Monoclonal Neutralizing Antibody Protects against Cutaneous and Mucosal Mouse Papillomavirus Infections.
Brendle SA; Li J; Cladel NM; Balogh KK; Booth J; Shearer DA; Walter V; Lu S; Christensen ND; Covington D; DeBroff J; Milici J; Zhu Y; Viscidi R; Hu J
J Virol; 2022 Aug; 96(16):e0070322. PubMed ID: 35920658
[TBL] [Abstract][Full Text] [Related]
4. Mouse Papillomavirus L1 and L2 Are Dispensable for Viral Infection and Persistence at Both Cutaneous and Mucosal Tissues.
Brendle S; Li JJ; Cladel NM; Shearer DA; Budgeon LR; Balogh KK; Atkins H; Costa-Fujishima M; Lopez P; Christensen ND; Doorbar J; Murooka TT; Hu J
Viruses; 2021 Sep; 13(9):. PubMed ID: 34578405
[TBL] [Abstract][Full Text] [Related]
5. Immune status, strain background, and anatomic site of inoculation affect mouse papillomavirus (MmuPV1) induction of exophytic papillomas or endophytic trichoblastomas.
Sundberg JP; Stearns TM; Joh J; Proctor M; Ingle A; Silva KA; Dadras SS; Jenson AB; Ghim SJ
PLoS One; 2014; 9(12):e113582. PubMed ID: 25474466
[TBL] [Abstract][Full Text] [Related]
6. Spontaneous and Vaccine-Induced Clearance of Mus Musculus Papillomavirus 1 Infection.
Jiang RT; Wang JW; Peng S; Huang TC; Wang C; Cannella F; Chang YN; Viscidi RP; Best SRA; Hung CF; Roden RBS
J Virol; 2017 Aug; 91(15):. PubMed ID: 28515303
[TBL] [Abstract][Full Text] [Related]
7. Mouse papillomavirus infections spread to cutaneous sites with progression to malignancy.
Cladel NM; Budgeon LR; Cooper TK; Balogh KK; Christensen ND; Myers R; Majerciak V; Gotte D; Zheng ZM; Hu J
J Gen Virol; 2017 Oct; 98(10):2520-2529. PubMed ID: 28942760
[TBL] [Abstract][Full Text] [Related]
8. A Novel
Spurgeon ME; Uberoi A; McGregor SM; Wei T; Ward-Shaw E; Lambert PF
mBio; 2019 Mar; 10(2):. PubMed ID: 30837335
[TBL] [Abstract][Full Text] [Related]
9. A Novel Model for Papillomavirus-Mediated Anal Disease and Cancer Using the Mouse Papillomavirus.
Blaine-Sauer S; Shin MK; Matkowskyj KA; Ward-Shaw E; Lambert PF
mBio; 2021 Aug; 12(4):e0161121. PubMed ID: 34281391
[TBL] [Abstract][Full Text] [Related]
10. Depo Medroxyprogesterone (DMPA) Promotes Papillomavirus Infections but Does Not Accelerate Disease Progression in the Anogenital Tract of a Mouse Model.
Hu J; Brendle SA; Li JJ; Walter V; Cladel NM; Cooper T; Shearer DA; Balogh KK; Christensen ND
Viruses; 2022 May; 14(5):. PubMed ID: 35632722
[TBL] [Abstract][Full Text] [Related]
11. Tracking vaginal, anal and oral infection in a mouse papillomavirus infection model.
Hu J; Budgeon LR; Cladel NM; Balogh K; Myers R; Cooper TK; Christensen ND
J Gen Virol; 2015 Dec; 96(12):3554-3565. PubMed ID: 26399579
[TBL] [Abstract][Full Text] [Related]
12. Disseminated mucosal papilloma/condyloma secondary to human papillomavirus.
Bishop JW; Emanuel JM; Sims KL
Am J Surg Pathol; 1998 Oct; 22(10):1291-5. PubMed ID: 9777992
[TBL] [Abstract][Full Text] [Related]
13. Mouse model of cervicovaginal papillomavirus infection.
Çuburu N; Cerio RJ; Thompson CD; Day PM
Methods Mol Biol; 2015; 1249():365-79. PubMed ID: 25348320
[TBL] [Abstract][Full Text] [Related]
14. Murine skin and vaginal mucosa are similarly susceptible to infection by pseudovirions of different papillomavirus classifications and species.
Handisurya A; Day PM; Thompson CD; Buck CB; Kwak K; Roden RB; Lowy DR; Schiller JT
Virology; 2012 Nov; 433(2):385-94. PubMed ID: 22985477
[TBL] [Abstract][Full Text] [Related]
15. Development of an in vivo infection model to study Mouse papillomavirus-1 (MmuPV1).
Uberoi A; Yoshida S; Lambert PF
J Virol Methods; 2018 Mar; 253():11-17. PubMed ID: 29253496
[TBL] [Abstract][Full Text] [Related]
16. Secondary infections, expanded tissue tropism, and evidence for malignant potential in immunocompromised mice infected with Mus musculus papillomavirus 1 DNA and virus.
Cladel NM; Budgeon LR; Cooper TK; Balogh KK; Hu J; Christensen ND
J Virol; 2013 Aug; 87(16):9391-5. PubMed ID: 23785210
[TBL] [Abstract][Full Text] [Related]
17. T cell-mediated antitumor immune response eliminates skin tumors induced by mouse papillomavirus, MmuPV1.
Joh J; Chilton PM; Wilcher SA; Zahin M; Park J; Proctor ML; Ghim SJ; Jenson AB
Exp Mol Pathol; 2017 Oct; 103(2):181-190. PubMed ID: 28939161
[TBL] [Abstract][Full Text] [Related]
18. Human Papillomavirus Infection and p16 Expression in Extragenital/Extraungual Bowen Disease in Immunocompromised Patients.
Švajdler M; Mezencev R; Kašpírková J; Kacerovská D; Kazakov DV; Ondič O; Michal M
Am J Dermatopathol; 2016 Oct; 38(10):751-7. PubMed ID: 26913849
[TBL] [Abstract][Full Text] [Related]
19. The Larynx is Protected from Secondary and Vertical Papillomavirus Infection in Immunocompetent Mice.
King RE; Rademacher J; Ward-Shaw ET; Hu R; Bilger A; Blaine-Sauer S; Spurgeon ME; Thibeault SL; Lambert PF
Laryngoscope; 2024 May; 134(5):2322-2330. PubMed ID: 38084790
[TBL] [Abstract][Full Text] [Related]
20. Rabbit genital tissue is susceptible to infection by rabbit oral papillomavirus: an animal model for a genital tissue-targeting papillomavirus.
Harvey SB; Cladel NM; Budgeon LR; Welsh PA; Griffith JW; Lang CM; Christensen ND
J Virol; 1998 Jun; 72(6):5239-44. PubMed ID: 9573297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
